View More Recent Stories

Jun 30, 2014 08:56AM Advaxis's Cancer Immunotherapy Featured on CBS News
Jun 23, 2014 07:30AM Advaxis Receives Notice of Allowance From U.S. Patent Office for Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-cHER2
Jun 12, 2014 07:30AM Advaxis to Present at BIO International Convention
Jun 10, 2014 06:30AM Advaxis Provides Business Update
Jun 9, 2014 07:30AM Advaxis Announces Business Update Conference Call
Jun 6, 2014 07:30AM Advaxis's ADXS-cHER2 Immunotherapy Continues to Demonstrate Significantly Prolonged Survival in Canine Osteosarcoma
May 31, 2014 07:30AM Advaxis Presents New Long-Term Survival Data Greater Than 24-Months at ASCO Annual Meeting
May 29, 2014 07:30AM Advaxis Selects inVentiv Health Clinical to Conduct Clinical Trials of Immunotherapy Candidates
May 27, 2014 07:30AM Advaxis's HER2 Immunotherapy Candidate Receives Orphan Drug Designation for Treatment of Osteosarcoma
May 5, 2014 07:30AM Advaxis to Initiate Clinical Development of ADXS-cHER2 Immunotherapy to Treat Pediatric Bone Cancer
Apr 24, 2014 08:45AM Advaxis to Present at 2014 American Society of Clinical Oncology Annual Meeting
Apr 14, 2014 07:30AM Japan Patent Office Issues Advaxis a Notice of Allowance for Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology
Apr 1, 2014 07:30AM Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology
Mar 20, 2014 12:45PM Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on Conference Call
Mar 18, 2014 07:30AM Advaxis Receives Patent in Japan for ADXS-HPV for the Treatment of Cervical Cancer
Mar 3, 2014 07:30AM Advaxis Cancer Immunotherapy Featured on CNN
Feb 18, 2014 07:30AM Advaxis to Participate in Canaccord Genuity Orphan Drug One-on-One Day
Feb 12, 2014 07:45AM Advaxis to Present at the Bloomberg 2014 State of Healthcare Summit
Feb 11, 2014 07:30AM Advaxis Engages SynCo Bio Partners for Manufacturing of ADXS-HPV, Its Lead Cancer Immunotherapy Program
Feb 5, 2014 07:30AM Advaxis Expands Collaboration With GRU Cancer Center at Georgia Regents University to Conduct Four Cancer Immunotherapy Clinical Trials
View More Recent Stories